Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Leuk Res. 2014 Nov 29;39(2):229–235. doi: 10.1016/j.leukres.2014.11.006

Figure 6. Simvastatin is synergistic with F10 for AML treatment and both reduces lipid raft levels and increases Fas clustering in lipid rafts.

Figure 6

(A,B) Effects of simvastatin and F10+simvastatin on the viability (A) and caspase 3/7 activity (B) of HL-60 cells.